16-172976-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PM1PP3BP6
The NM_000517.6(HBA2):c.64G>C(p.Ala22Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000517.6 missense
Scores
Clinical Significance
Conservation
Publications
- alpha thalassemia spectrumInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- erythrocytosis, familial, 7Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- hemoglobin M diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Hb Bart's hydrops fetalisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hemoglobin H diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Heinz body anemiaInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- methemoglobinemia, alpha typeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000517.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HBA2 | NM_000517.6 | MANE Select | c.64G>C | p.Ala22Pro | missense | Exon 1 of 3 | NP_000508.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HBA2 | ENST00000251595.11 | TSL:1 MANE Select | c.64G>C | p.Ala22Pro | missense | Exon 1 of 3 | ENSP00000251595.6 | ||
| HBA2 | ENST00000484216.1 | TSL:1 | c.31G>C | p.Ala11Pro | missense | Exon 1 of 2 | ENSP00000495899.1 | ||
| HBA2 | ENST00000482565.1 | TSL:1 | n.83G>C | non_coding_transcript_exon | Exon 1 of 2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 4754Hom.: 0 Cov.: 2
GnomAD2 exomes AF: 0.0000188 AC: 1AN: 53330 AF XY: 0.0000372 show subpopulations
GnomAD4 exome AF: 0.0000219 AC: 9AN: 411840Hom.: 1 Cov.: 0 AF XY: 0.0000323 AC XY: 7AN XY: 216496 show subpopulations
Age Distribution
GnomAD4 genome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 4724Hom.: 0 Cov.: 2 AF XY: 0.00 AC XY: 0AN XY: 2328
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
The HB2 c.64G>C (p.Ala22Pro), also known as Hb Fontainebleau, variant is reported as having normal stability (see HbVar, http://globin.bx.psu.edu/cgi-bin/hbvar/counter, PMID: 2599878 (2009)). This variant has been observed in a screening study of alpha thalassemia carriers (PMID: 29627922 (2018)). It has also been detected in an individual with suspected hemoglobinopathy (PMID: 38708170 (2024)). The variant has been reported in homozygous and compound heterozygous individuals with microcytosis (PMID: 22461654 (2012), 24826794 (2014), 26036869 (2015), and 30728682 (2019)) as well as in individuals with normal red cell indices (PMID: 19657841 (2009)). Based on the available information, we are unable to determine the clinical significance of this variant.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at